⌘K

Login Start Free

Home/Filings/4/0001127602-20-023449

4//SEC Filing

Doyle Anthony 4

Accession 0001127602-20-023449

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 4:31 PM ET

Size

4.2 KB

Accession

0001127602-20-023449

Insider Transaction Report

Form 4

Period: 2020-08-11

BIOCRYST PHARMACEUTICALS INCBCRX

Chief Financial Officer

Transactions

Purchase
Common Stock
2020-08-11$4.08/sh+54,000$220,320→ 54,000 total

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001808688

Filing Metadata

Form type: 4
Filed: Aug 11, 8:00 PM ET
Accepted: Aug 12, 4:31 PM ET
Size: 4.2 KB

View on SEC.gov